نتایج جستجو برای: refractory nhl lymphoma

تعداد نتایج: 155852  

Journal: :Hematological Oncology 2023

Introduction: Treatment options for relapsed or refractory (r/r) B-cell non-Hodgkin lymphomas (B-NHL) have broadened towards T-cell engaging therapies, including CD19-targeting chimeric antigen receptor T-cells (CD19-CAR) and bispecific antibodies (CD19-BsAb). Although CD19-CAR CD19-BsAb induce durable responses in some r/r B-NHL patients, response remains heterogenous a significant proportion ...

Journal: :The Medical journal of Malaysia 2003
S C Peh J Shaminie P Jayasurya J Hiew

Lymphomas, ranked twelve among all cancers world-wide in the 1990s, in which it is more prevalent in males compared to females. A previous study on lymphomas in East Malaysia for a period of 3 years from 1981-1983 showed that the pattern of lymphomas conformed to the general pattern observed in Asia. Current study reviews lymphoma cases from the Department of Pathology, Queen Elizabeth Hospital...

2015
Moosa Patel Vinitha Philip Tanvier Omar Dianne Turton Geoff Candy Atul Lakha Sugeshnee Pather

Human immunodeficiency virus (HIV) infection is endemic in South Africa. Non-Hodgkin lymphoma (NHL) occurs with increased frequency in HIV seropositive individuals. The increase in NHL has been more marked in the last decade, with HIV being the major contributor to this increase. More than 70% of the adult NHL patients at Chris Hani Baragwanath Academic Hospital (CHBAH), Soweto, Johannesburg, a...

2013
P. L. Zinzani J. M. Vose M. S. Czuczman C. B. Reeder C. Haioun J. Polikoff H. Tilly L. Zhang K. Prandi J. Li T. E. Witzig

BACKGROUND Mantle cell lymphoma (MCL) is an uncommon type of non-Hodgkin lymphoma with poor overall prognosis, requiring the development of new therapies. Lenalidomide is an immunomodulatory agent demonstrating antitumor and antiproliferative effects in MCL. We report results from a long-term subset analysis of 57 patients with relapsed/refractory MCL from the NHL-003 phase II multicenter study...

2012

The aim of this study was to estimate the frequency of EBV infection in Hodgkin‘s lymphoma (HL) and non-Hodgkin‘s lymphoma (NHL) occurring in Jordanian patients. A total of 55 patients with lymphoma were examined in this study. Of 55 patients, 30 and 25 were diagnosed as HL and NHL, respectively. The four HL subtypes were observed with the majority of the cases exhibited the mixed cellularity (...

Journal: :Cell 2010
Mark P. Chao Ash A. Alizadeh Chad Tang June H. Myklebust Bindu Varghese Saar Gill Max Jan Adriel C. Cha Charles K. Chan Brent T. Tan Christopher Y. Park Feifei Zhao Holbrook E. Kohrt Raquel Malumbres Javier Briones Randy D. Gascoyne Izidore S. Lossos Ronald Levy Irving L. Weissman Ravindra Majeti

Monoclonal antibodies are standard therapeutics for several cancers including the anti-CD20 antibody rituximab for B cell non-Hodgkin lymphoma (NHL). Rituximab and other antibodies are not curative and must be combined with cytotoxic chemotherapy for clinical benefit. Here we report the eradication of human NHL solely with a monoclonal antibody therapy combining rituximab with a blocking anti-C...

Journal: :Saudi medical journal 2009
Shad S Akhtar Imran-ul Haque Sharief M Wafa Hala El-Saka Atef M Saroor Hisham M Nadrah

OBJECTIVE To determine the frequency of various types of malignant lymphoma (ML) in the Al-Qassim region of Kingdom of Saudi Arabia (KSA) according to recently introduced the WHO classification. METHODS For this retrospective analysis, material was available in 385 out of 519 cases diagnosed as ML from 1988-2007. Morphological assessment was followed by immunohistochemistry using a panel of a...

2017
Yu-Hsiang Chiu Chi-Hsiang Chung Kuen-Tze Lin Chin-Sheng Lin Jia-Hong Chen Hsiang-Cheng Chen Ren-Yeong Huang Chi-Tsung Wu Feng-Cheng Liu Wu-Chien Chien

Sjögren syndrome (SS) is commonly known to be correlated with lymphoma. This study included 16,396 individuals in the SS cohort and 65,584 individuals in the non-SS cohort, all of whom were enrolled in the Taiwan National Health Insurance database between 2000 and 2010. We evaluated the risk factors of non-Hodgkin's lymphoma (NHL) in the primary SS cohort by applying a Cox multivariable proport...

Journal: :Blood 2003
Jobst Greeve Antje Philipsen Kristina Krause Wolfram Klapper Klaus Heidorn Brian E Castle Joe Janda Kenneth B Marcu Reza Parwaresch

Activation-induced cytidine deaminase (AID) induces somatic hypermutation (SHM), class switch recombination (CSR), and immunoglobulin gene conversion in B-lymphocytes. Here we report for the first time the expression of AID in healthy human B-lymphocytes and in B-cell non-Hodgkin lymphomas (B-NHL). AID mRNA expression in humans is restricted to the CD19(+)CD38(+)IgD(-) germinal center cells, na...

2014
Michael C. R. Alavanja Jonathan N. Hofmann Charles F. Lynch Cynthia J. Hines Kathryn H. Barry Joseph Barker Dennis W. Buckman Kent Thomas Dale P. Sandler Jane A. Hoppin Stella Koutros Gabriella Andreotti Jay H. Lubin Aaron Blair Laura E. Beane Freeman Suminori Akiba

Farming and pesticide use have previously been linked to non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL) and multiple myeloma (MM). We evaluated agricultural use of specific insecticides, fungicides, and fumigants and risk of NHL and NHL-subtypes (including CLL and MM) in a U.S.-based prospective cohort of farmers and commercial pesticide applicators. A total of 523 cases occurre...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید